Histone deacetylase 3 is selectively involved in L3MBTL2-mediated transcriptional repression  by Yoo, Jung-Yoon et al.
FEBS Letters 584 (2010) 2225–2230journal homepage: www.FEBSLetters .orgHistone deacetylase 3 is selectively involved in L3MBTL2-mediated
transcriptional repression
Jung-Yoon Yoo a,b,1, Kyung-Chul Choi a,b,1, HeeBum Kang a,b, Young Jun Kim c, Jeongmin Lee d, Woo Jin Jun e,
Mi-Jeong Kim a,b, Yoo-Hyun Lee f, Ok-Hee Lee g, Ho-Geun Yoon a,b,*
aDepartment of Biochemistry and Molecular Biology, Institute of Genetic Science, Center for Chronic Metabolic Disease Research, Yonsei University College of Medicine, South Korea
bBrain Korea 21 Project for Medical Sciences Korea, Yonsei University College of Medicine, South Korea
cDepartment of Food and Biotechnology, Korea University, Chungnam, South Korea
dDepartment of Medical Nutrition, Kyung Hee University, Kyunggi-do, 446-701, South Korea
eDepartment of Food and Nutrition, Chonnam National University, Gwangju, South Korea
fDepartment of Food and Nutrition, The University of Suwon, South Korea
g Severance Hospital Integrative Research Institute for Cerebral and Cardiovascular Disease, Yonsei University Health System, Seoul, South Korea
a r t i c l e i n f oArticle history:
Received 29 January 2010
Revised 15 March 2010
Accepted 31 March 2010
Available online 10 April 2010





Transcription0014-5793/$36.00  2010 Federation of European Bio
doi:10.1016/j.febslet.2010.03.048
Abbreviations: L3MBTL2, L(3)mbt-like 2; HDAC3,
histone methyltransferase; ChIP, chromatin immunop
* Corresponding author at: Department of Biochem
Institute of Genetic Science, Center for Chronic Metab
University College of Medicine, South Korea. Fax: +82
E-mail address: yhgeun@yuhs.ac (H.-G. Yoon).
1 These authors contributed equally to this work.a b s t r a c t
This is the ﬁrst report that L(3)mbt-like 2 (L3MBTL2) speciﬁcally interacts with the histone deacetyl-
ase domain of histone deacetylase 3 (HDAC3) via its MBT domain. Here, we show that L3MBTL2 selec-
tively interacts with HDAC3, but not other class I HDACs. An in vitro peptide-binding assay
demonstrated the speciﬁc association of HDAC3 with methylated histone-K20 tail and L3MBTL2.
Furthermore, depletion of HDAC3 resulted in a decrease of methylated K20-H4, as well as an
increase in acetylated histone H3. Consequently, HDAC3 knock-down selectively suppressed
L3MBTL2-mediated transcriptional repression. Taken together, our results reveal the concerted
action of both HDAC3 and L3MBTL2 in histone deacetylation and methylation-dependent transcrip-
tional repression.
Structured summary:
MINT-7719975: L3MBTL2 (uniprotkb:Q969R5) and HDAC3 (uniprotkb:O15379) colocalize (MI:0403) by
ﬂuorescence microscopy (MI:0416)
MINT-7719941, MINT-7719921: L3MBTL2 (uniprotkb:Q969R5) binds (MI:0407) to HDAC3 (uni-
protkb:O15379) by pull down (MI:0096)
MINT-7719991: HDAC3 (uniprotkb:O15379) physically interacts (MI:0915) with L3MBTL2 (uni-
protkb:Q969R5) by anti bait coimmunoprecipitation (MI:0006)
MINT-7719958: L3MBTL2 (uniprotkb:Q969R5) physically interacts (MI:0915) with HDAC3 (uni-
protkb:O15379) by anti tag coimmunoprecipitation (MI:0007)
MINT-7719897: HDAC3 (uniprotkb:O15379) physically interacts (MI:0915) with L3MBTL2 (uni-
protkb:Q969R5) by two hybrid (MI:0018)
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The malignant-brain-tumor (MBT) protein was ﬁrst identiﬁed
as the Drosophila tumor-suppressor protein, L(3)MBT, andchemical Societies. Published by E
histone deacetylase 3; HMT,
recipitation
istry and Molecular Biology,
olic Disease Research, Yonsei
2 312 5041.mutations of the D-l(3)mbt gene cause malignant transformation
in the larval brain [1]. Recent structural studies have demonstrated
that the MBT domain of human L3MBTL1 is required for recogni-
tion of methylated histone H4-K20 and preferentially binds to
mono- and dimethylated H3-K4 and dimethylated H4-K20 [2].
SCML2 contains two MBT repeats and binds to mono-methylated
lysine residues through a second MBT domain [3]. L(3)mbt-like 2
(L3MBTL2), a human homolog of Drosophila Sfmbt, is critical for
Hox gene silencing, has been recently identiﬁed as a member of
the four-MBT domain protein family [4]. Crystallographic analysis
has further revealed that L3MBTL2 preferentially recognizes thelsevier B.V. All rights reserved.
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though the molecular basis of both L3MBTL1 and Drosophila Sfmbt
in the process of gene silencing has been well deﬁned [6,7], the
functional roles of L3MBTL2 in transcriptional regulation are not
yet known.
In this study, we ﬁrst identiﬁed HDAC3 as a novel L3MBTL2-
interacting protein and investigated the functional role of HDAC3
in L3MBTL2-mediated transcriptional repression. We found that
L3MBTL2 speciﬁcally interacted with the histone deacetylase do-
main of HDAC3 via its MBT domain, and that HDAC3 physically
associated with methylated H4-K20-bound L3MBTL2. We have
also demonstrated that among class I HDACs, L3MBTL2 selectively
interacts with HDAC3, which is exclusively involved in L3MBTL2-
mediated transcriptional repression. Together, these data provide
the ﬁrst evidence that HDAC3 is involved in L3MBTL2-mediated
transcriptional repression, implicating HDAC3 in histone methyla-
tion-dependent repression.
2. Materials and methods
2.1. Cell culture, reagents and DNA constructs
Human HEK293 cells were maintained in DMEM with 10% fetal
bovine serum (Hyclone). Cells were seeded at a density of 60–70%
conﬂuency for transfection. Cells in 6-well plates were supple-
mented with fresh medium 2 h before transfection with 1.5 lgFig. 1. L3MBTL2 speciﬁcally interacts with HDAC3. (A) L3MBTL2 interacts with endogen
was incubated with either GST-HDAC3 or GST-L3MBTL2 recombinant protein and th
autoradiography (upper panel). For immunoprecipitation, HEK 293 cell lysates were im
(lower panel). (B) Immunostaining analysis showed that L3MBTL2 and HDAC3 co-local
cells, cells were ﬁxed, and then immunostained with the indicated antibodies. (C) A s
translation or immunoprecipitation (upper panel) and GST-HDAC3 proteins used in th
L3MBTL2. L3MBTL2 deletion mutants were transfected into HEK293 cells with Flag-HDAC
with the antibody against Flag. (E) L3MBTL2 interacts with the histone deacetylase dom
mutants were incubated with GST-HDAC3 deletion mutants and the bound in vitro-trans
autoradiography.DNA, according to manufacturer’s protocol for Effectin Transfection
(Qiagen). After 2–3 h incubation, cells were treated with medium
supplemented with charcoal-dextran-treated FBS. Cells were incu-
bated at 37 C for 24 h, washed with PBS, and harvested. Cell ly-
sates were prepared for luciferase assays according to
manufacturer’s instructions (Promega). Data were obtained from
at least three sets of transfections and presented as mean values.
The various L3MBTL2 constructs were generated by PCR and
cloned into the plasmid, pSG5-KF2M1 (Sigma). The plasmids for re-
porter gene assays (GAL4-DBD, 17XGAL4-Tk-Luc, and pSV40) were
described previously [8]. For GST-fusion proteins, various con-
structs for HDAC3 and L3MBTL2 were created by PCR from cDNA
clones, followed by ligation into the pGEX4T-1 GST expression vec-
tor (Amersham Pharmacia Biotech). The L3MBTL2 clone was ac-
quired from 21C Human Frontier Human Gene Bank (Daejeon,
Korea), and conﬁrmed by sequencing.
2.2. In vitro pull-down assay and immunoprecipitation
Both GST-fused HDAC3 and L3MBTL2 were expressed in Esche-
richia coli. Recombinant proteins were puriﬁed by glutathione-re-
sin (Pharmacia) afﬁnity chromatography, according to
manufacturer’s instructions. All in vitro translations and [35S]-
methionine labeling were performed using the indicated expres-
sion constructs and the TNT T7 quick coupled transcription/trans-
lation kit from Promega. The concentrations of GST-fused proteinsous HDAC3, but not other HDACs. In vitro translated, 35S-labeled L3MBTL2 or HDC3
e bound in vitro translated proteins were subjected to SDS–PAGE followed by
munoprecipitated and subsequently immunoblotted with antibodies, as indicated
ize in the nucleus. Flag-L3MBTL2 expression plasmid was transfected into HEK293
chematic diagram of the various deletion mutants of L3MBTL2 for either in vitro
e mapping studies (lower panel). (D) HDAC3 interacts with the MBT domain of
3 plasmid. Cell lysates were immunoprecipitated and subsequently immunoblotted
ain of HDAC3 via its MBT domain. In vitro translated 35S-labeled L3MBTL2 deletion
lated L3MBTL2 deletion mutants proteins were subjected to SDS–PAGE followed by
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obtained from 50-ml culture were incubated with glutathione-re-
sin. The resin was incubated with 35S-labeled, TNT-expressed
L3MBTL2 for 4 h and washed extensively with 20 mM HEPES/pH
7.5, 0.5 mM EDTA, 20% glycerol, 100 mM NaCl. The bound proteins
were eluted in 2 SDS loading buffer (100 mM Tris–HCl/pH 6.8, 4%
SDS, 20% glycerol, 200 mM b-mercaptoethanol), separated on 10%
SDS–polyacrylamide gels, and analyzed by autoradiography.
Immunoprecipitation and the biotinylated histone peptide-
binding assay were performed as described previously [9]. Western
analysis was performed using commercial antibodies, including
anti-HDAC1/, HDAC3, and HDAC8 antibody (Santa Cruz Biotechnol-
ogy). Flag-speciﬁc monoclonal antibody and Myc-speciﬁc poly-
clonal antibody were from Sigma. Biotinylated histone peptides
were synthesized by Peptron (Korea).
2.3. Chromatin immunoprecipitation (ChIP) assays and siRNAs
The ChIP assays and siRNA experiments were performed, as de-
scribed [10]. The antibodies against modiﬁed histones were pur-
chased from Upstate Biotechnology. The antibody against
GAL4(DBD) was obtained from Santa Cruz Biotechnology. The siR-
NAs for HDAC1, HDAC2, HDAC3, and HDAC8 were chemically syn-
thesized (GenePharm Co). The primers used in the ChIP assays and
the siRNA sequences are reported in Supplementary Table 1.Fig. 2. HDAC3 is associated with methylated histone H4-K20-bound L3MBTL2. (A) L3MBT
L3MBTL2 was incubated with biotinylated-histone tail peptides and the bound in vitro-
Immunoprecipitated L3MBTL2 speciﬁcally associates with dimethylated H4-K20. Flag-ta
either histone H4 tail or biotinylated-dimethyl H4-K20 peptides and subsequently imm
sufﬁcient for binding to methylated H4-K20. A schematic diagram is shown of the dele
deletion mutants were incubated with either histone H4 tail or biotinylated-dimethyl H4-
SDS–PAGE followed by autoradiography (lower panel). (D) HDAC3 associates with meth
translated 35S-labeled L3MBTL2 and HDAC3 were incubated with either histone H4 ta
L3MBTL2 proteins were subjected to SDS–PAGE followed by autoradiography. (E) Phys
in vitro pull-down assays followed by western blot analysis. HEK293 cells were transfect
immunoprecipitated with histone H4 tail or biotinylated-modimethyl H4-K20 peptides a3. Results
3.1. The MBT protein, L3MBTL2, speciﬁcally interacts with HDAC3,
both in vitro and in vivo
To better understand the functional diversity of HDAC3 in the
context of transcriptional repression, we performed a yeast two-
hybrid assay to identify novel HDAC3-interacting proteins. A hu-
man HeLa cell cDNA library was screened with Gal4p-fusions of
the histone deacetylase domain (amino acid 1–371) and catalytic
domain of HDAC3 (amino acid 377–390). cDNAs were isolated
from positive clones and subsequent DNA sequencing was per-
formed. Based on the sequence analysis, we identiﬁed the MBT
protein, L3MBTL2, as a putative HDAC3-interacting protein. To val-
idate the screening data, we performed both in vitro and in vivo
pull-down assays. The results in Fig. 1A (upper panel) demonstrate
that in vitro translated 35S-labeled L3MBTL2 or HDAC3 speciﬁcally
bound to each other, but not to the control (Supplementary
Fig. 1A). Next, we asked whether L3MBTL2 interacts with other
class I HDACs. We found that Flag-tagged L3MBTL2 speciﬁcally
interacted with endogenous HDAC3, but not HDAC1 or HDAC8. In
vitro pull-down assays veriﬁed the speciﬁc interaction between
HDAC3 and L3MBTL2 (Supplementary Fig. 1B). Collectively, these
results indicate that HDAC3 speciﬁcally interacts with L3MBTL2,
both in vitro and in vivo.L2 binds to methylated histone H4-K20 tail peptides. In vitro translated, 35S-labeled
translated L3MBTL2 was subjected to SDS–PAGE followed by autoradiography. (B)
gged L3MBTL2 was transfected into HEK293 cells. Cell lysates were incubated with
unoblotted with antibody against Flag. (C) The three MBT domains of L3MBTL2 are
tion mutants for L3MBTL2 (upper panel). In vitro translated 35S-labeled L3MBTL2
K20 peptides and the bound in vitro-translated L3MBTL2 proteins were subjected to
ylated H4-K20-bound L3MBTL2, as shown by in vitro pull-down assays. In vitro co-
il or biotinylated-modimethyl H4-K20 peptides and the bound in vitro translated
ical association of HDAC3 with methylated H4-K20-bound L3MBTL2, as tested by
ed with both Flag-L3MBTL2 and Myc-HDAC3 expression plasmids. Cell lysates were
nd subsequent western blot analysis was performed with the indicated antibodies.
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domain of L3MBTL2
We next investigated the structure and function of L3MBTL2
and HDAC3 with respect to their interaction domains. To deter-
mine the cellular localization of both HDAC3 and L3MBTL2, we
performed immunostaining analysis in HEK293 cells co-transfec-
ted with Flag-tagged LAMBTL2 and HA-tagged HDAC3. We found
that HDAC3 and L3MBTL2 mainly co-localized in the nucleus
(Fig. 1B).
To elucidate the structure and function of L3MBTL2 and HDAC3
with respect to their interaction domains, we next mapped the
interaction domains of L3MBTL2 and HDAC3. For this experiment,
the L3MBTL2 protein was divided into three fragments, as shown
in Fig. 1C, and their interaction with HDAC3 was tested by
in vitro pull-down assays (Supplementary Fig. 1C). The results
showed that the in vitro-translated L3MBTL2 (179–705) fragment
containing the MBT domain interacted with the histone deacetyl-
ase domain of GST-HDAC3 (Fig. 1D and E and Supplementary
Fig. 1D). Taken together, we concluded that L3MBTL2 interacts
with histone deacetylase domain of HDAC3 via its MBT domain.
Since the MBT domain is known to interact with methylated
histone H4 tails [11], we next tested whether L3MBTL2 also spe-
ciﬁcally interacts with methylated histone H4-K20 tails using
synthetic peptides against mono-, di-, and tri-methylated histone
H4-K20 tails (amino acid 1–24 of histone H4). As shown in
Fig. 2A, the in vitro-translated L3MBTL2 speciﬁcally interacted
with all methylated histone H4-K20 tail peptides, although theFig. 3. L3MBTL2 is a histone deacetylase activity-dependent transcriptional repressor. (A
cells were co-transfected with a GAL4-driven luciferase reporter plasmid and the indicate
obtained by SV-40 co-transfection. Results are presented as the means of two independe
mediated transcriptional repression. HEK293 cells were transfected with a GAL4-driven
suppression of L3MBTL2-mediated transcriptional activity. HEK293 cells were transfecte
indicated. (D) Suppression of HDAC3 function resulted in a reduction in methylated H
GAL4-fused proteins and a GAL4-driven luciferase reporter plasmid with or without siRN
percentage of input. The results are shown as means ± S.D. calculated from three indeperelative binding afﬁnity of L3MBTL2 to the tri-methylated H4-
K20 peptide was less than to the mono- and dimethylated pep-
tides. In addition, in vivo pull-down assays conﬁrmed the speciﬁc
binding of L3MBTL2 with methylated histone H4-K20 tail, indicat-
ing an in vivo association of L3MBTL2 with methylated histone
H4-K20 (Fig. 2B). Next, we asked which MBT domains are re-
quired for the interaction of L3MBTL2 with methylated histone
H4-K20 tails. To do this, the L3MBTL2 protein was divided into
four fragments, as shown in Fig. 2C, and their interaction with
methylated histone H4-K20 tail peptides was tested in in vitro
pull-down assays. The results demonstrated that three MBT re-
peats are sufﬁcient for interaction with methylated histone H4-
K20 tail. This interaction seems to be methylation-dependent be-
cause control and acetylated histone H4 failed to interact with
L3MBTL2, conﬁrming the speciﬁc interaction between L3MBTL2
and methylated histone H4-K20 tail (Fig. 2C, upper panel). Based
on knowledge of the speciﬁc association of L3MBTL2 with both
methylated histone H4-K20 tail and HDAC3, we next looked for
an interaction between HDAC3 and methylated histone-K20
tail-bound L3MBTL2. For this experiment, in vitro co-translated
L3MBTL2 and HDAC3 were incubated with streptavidin-prebound
peptides as indicated, and in vitro pull-down assays were then
performed. Strikingly, both HDAC3 and L3MBTL2 bound the
methylated histone H4-K20 tail peptides, but not the control pep-
tide (Fig. 2D). Moreover, co-immunoprecipitation analysis in cells
co-transfected with both HDAC3 and L3MBTL2 conﬁrmed the
interaction of HDAC3 and methylated histone-K20 tail-bound
L3MBTL2 (Fig. 2E).) L3MBTL2 repressed transcriptional activity in a dose-dependent manner. HEK293
d expression plasmids. The fold repression shown is relative to the luciferase activity
nt experiments performed in triplicate. (B) HDAC activity is required for L3MBTL2-
luciferase reporter plasmid with or without TSA. (C) Depletion of HDAC3 led to the
d with a GAL4-driven luciferase reporter plasmid and treated with TSA or siRNAs as
4-K20 in L3MBTL2-occupied promoter region. HEK293 cells were transfected with
As as indicated. The results were analyzed by real-time PCR and are shown as the
ndent experiments.
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mediated transcriptional repression
Since increased H4-K20 methylation is a hallmark of transcrip-
tional repression [6], we next tested whether L3MBTL2 mediates
transcriptional repression. As shown in Fig. 3A, a GAL4(DBD) fusion
of L3MBTL2 repressed a TK-luciferase reporter bearing GAL4-bind-
ing sites, in a dose-dependent manner. The degree of repression
was similar to that of the GAL4-fused NCoR domain, which was
used as a positive control [8] (Fig. 3B). The repression activity of
L3MBTL2 appears to be dependent on histone deacetylase activity
because TSA treatment signiﬁcantly relieved the both NCoR and
L3MBLT-mediated repression. Since TSA treatment inhibited the
L3MBTL2-mediated transcriptional repression, we next examined
the selective involvement of HDAC3 in transcriptional repression
by L3MBTL2 using small interference RNA (siRNA) to knock-down
HDAC3. As shown in Fig. 4A, two sets of siRNA speciﬁc to HDAC3
were able to reduce the level of HDAC3 by more than 90% when
was used at a concentration of 1 nM. Similar to TSA treatment,
the depletion of HDAC3 dramatically relieved the transcriptional
repression caused by L3MBTL2, indicating that HDAC3 is key mod-
ulator of L3MBTL2-mediated transcriptional repression (Fig. 3C). In
addition, knock-down with siHDAC3 had no apparent effect on the
luciferase activity in the presence of GAL4(DBD), excluding the
possibility of off-target effects.
Finally, using a ChIP assay, we found that both TSA treatment
and HDAC3 knock-down resulted in a decrease in methylated
K20-H4 and an increase in acetylated histone H3, which are hall
marks for transcriptional activation. These data provide evidence
that histone deacetylation by HDAC3 is essential for methylation-
dependent transcriptional repression by L3MBTL2 (Fig. 3D).
We next investigated whether, among class I HDACs, the inhibi-
tion of L3MBTL2-mediated transcription is unique to HDAC3. We
designed and conﬁrmed the efﬁcacy of siRNA against class I HDACs,
including HDAC1, HDAC2, HDAC3, and HDAC8 (Fig. 4A). As a con-
trol, we measured the levels of TBL1, a component of HDAC3 co-
repressor complex, which showed no signiﬁcant change after any
siRNA treatment. The effect of HDAC3 knock-down on the
L3MBTL2-mediated transcriptional repression seems to be speciﬁc,
since the siRNA against other class I HDACs failed to de-repress
transcription of the reporter by L3MBTL2 (Fig. 4B). We concludeFig. 4. HDAC3 is the only class I HDAC involved in L3MBTL2-mediated transcriptional rep
were analyzed by western blotting using antibodies, as indicated. (B) Of the class I HDAC
ﬁrst transfected with siRNAs as indicated, and harvested after 2 days. Whole cell extracts
three independent experiments.that HDAC3 is the only class I HDAC protein involved in
L3MBTL2-mediated transcriptional repression.
4. Discussion
Histone lysine methylation is a hallmark of both gene activation
and repression, depending on the site and degree of methylation.
Histone methylation at speciﬁc lysine residues results in various
downstream events mediated by histone code-speciﬁc adaptor
proteins [6]. In particular, tri-methylation at lysine 9 of histone
H3 (H3-K9) and at lysine 20 of histone H4 (H4-K20) governed by
the histone methyltransferases (HMTs), SUV39H1/2 and
SUV420H1/2, respectively, have emerged as hallmarks of pericen-
tric heterochromatin [12]. For concerted gene silencing, in addition
to histone methyltransferase and methyl-lysine binding proteins,
histone deacetylases are known to be involved in the formation
of heterochromatin. For example, in the case of Suv39 HMTase-
dependent imprinting, HP1 binds to tri-methylated H3-K9 through
its methyl-lysine binding domain (MLBD) and interacts with Suv39
HMTase and histone deacetylases (HDACs), in vivo, forming a
repressive complex. Until now, several groups of methyl-lysine
binding protein domains were known to bind to diverse relevant
lysine residues of histones. Among them, the MBT domain proteins
have been shown to interact with methylated H3-K4, H3-K9, and
H4-K20, and to mediate subsets of gene silencing [11]. In particu-
lar, L3MBTL2 has been shown to recognize the methylated H4-K20,
however, the molecular basis for how or whether L3MBTL2 medi-
ates transcriptional repression is unresolved. Since the L3MBTL2
appears to be the human homolog of Drosophila Sfmbt, which
has been reported to bind methylated H4-K20 and mediate HOX
gene silencing [7], L3MBTL2 has been presumed to be a transcrip-
tional repressor.
Here, we report for the ﬁrst time that HDAC3 is a novel
L3MBTL2-interacting protein and H4-K20 methylation-speciﬁc
adaptor protein. The interaction between L3MBTL2 and class I
HDACs seems to be speciﬁc to HDAC3, since L3MBTL2 failed to
interact either HDAC1 or HDAC8. Importantly, the siRNA knock-
down of class I HDACs showed that only HDAC3 is critical for
L3MBTL2-mediated transcriptional repression. Additional studies
of endogenous target genes regulated by both L3MBTL2 and
HDAC3 will be needed to unravel the precise mechanism behindression. (A) ‘Knock-down’ components of HDACs by siRNAs. The levels of each HDAC
s, only HDAC3 is essential for mediating repression by L3MBTL2. HEK293 cells were
were used in luciferase assays. The results are shown as means ± S.D. calculated from
2230 J.-Y. Yoo et al. / FEBS Letters 584 (2010) 2225–2230the functional interplay between these two enzymes in the modu-
lation of histone acetylation and the methylation code.
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